Dashboard
Manage Tickers

PLX Protalix BioTherapeutics, Inc.

NYSE protalix.com


$ 2.36 $ 0.05 (2.16 %)    

Friday, 24-Oct-2025 15:59:54 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 625.00 $ 0.00 (0 %)
DIA $ 474.74 $ 0.00 (0 %)
SPY $ 682.90 $ 0.00 (0 %)
TLT $ 91.28 $ 0.00 (0 %)
GLD $ 371.72 $ 0.00 (0 %)
$ 2.36
$ 2.32
$ 2.36 x 400
$ 2.45 x 1,000
-- - --
$ 1.03 - $ 3.10
740,682
na
188.17M
$ 0.76
$ 29.99
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-09-2025 03-31-2025 10-Q
3 03-17-2025 12-31-2024 10-K
4 11-14-2024 09-30-2024 10-Q
5 08-14-2024 06-30-2024 10-Q
6 05-10-2024 03-31-2024 10-Q
7 03-14-2024 12-31-2023 10-K
8 11-06-2023 09-30-2023 10-Q
9 08-07-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 02-27-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-15-2022 06-30-2022 10-Q
14 05-16-2022 03-31-2022 10-Q
15 03-31-2022 12-31-2021 10-K
16 11-15-2021 09-30-2021 10-Q
17 08-16-2021 06-30-2021 10-Q
18 05-14-2021 03-31-2021 10-Q
19 03-30-2021 12-31-2020 10-K
20 10-29-2020 09-30-2020 10-Q
21 08-10-2020 06-30-2020 10-Q
22 06-01-2020 03-31-2020 10-Q
23 03-12-2020 12-31-2019 10-K
24 11-07-2019 09-30-2019 10-Q
25 08-08-2019 06-30-2019 10-Q
26 05-06-2019 03-31-2019 10-Q
27 03-18-2019 12-31-2018 10-K
28 11-07-2018 09-30-2018 10-Q
29 08-09-2018 06-30-2018 10-Q
30 05-09-2018 03-31-2018 10-Q
31 03-06-2018 12-31-2017 10-K
32 11-08-2017 09-30-2017 10-Q
33 08-09-2017 06-30-2017 10-Q
34 05-10-2017 03-31-2017 10-Q
35 03-16-2017 12-31-2016 10-K
36 11-09-2016 09-30-2016 10-Q
37 08-08-2016 06-30-2016 10-Q
38 05-09-2016 03-31-2016 10-Q
39 03-08-2016 12-31-2015 10-K
40 11-09-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

why-is-protalix-biotherapeutics-stock-falling-on-friday
Why Is Protalix BioTherapeutics Stock Fall...
10/17/2025 15:23:15

EMA issues a negative opinion on Protalix and Chiesi's Elfabrio revised dosing for Fabry disease, citing insufficient data ...

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
10/17/2025 12:13:10

protalix-biotherapeutics-says-chmp-denies-approval-for-every-4-week-elfabrio-regimen-in-eu-maintains-2-week-dosing-status-quo
Protalix BioTherapeutics Says CHMP Denies ...
10/17/2025 11:03:02

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/02/2025 21:06:15

protalix-biotherapeutics-q2-sales-15658m-beat-13546m-estimate
Protalix BioTherapeutics Q2 Sales $15.658M...
08/14/2025 10:51:53

Protalix BioTherapeutics (AMEX:PLX) reported quarterly sales of $15.658 million which beat the analyst consensus estimate of $1...

Core News & Articles
Earnings Scheduled For August 14, 2025
08/14/2025 08:32:32

preview-protalix-biotherapeuticss-earnings
Preview: Protalix BioTherapeutics's Earnings
08/13/2025 17:02:31

protalix-biotherapeutics-appoints-gilad-mamlok-as-svp-and-cfo-effective-august-24-2025-succeeding-eyal-rubin
Protalix BioTherapeutics Appoints Gilad Ma...
07/21/2025 10:51:50

protalix-biotherapeutics-added-to-russell-3000-and-russell-2000-indexes-effective-june-27-2025-as-part-of-2025-russell-indexes-annual-reconstitution
Protalix BioTherapeutics Added To Russell ...
06/30/2025 10:52:45

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
05/09/2025 12:10:06

protalix-biotherapeutics-q1-eps-005-misses-003-estimate-sales-1011m-miss-2160m-estimate
Protalix BioTherapeutics Q1 EPS $(0.05) Mi...
05/09/2025 10:53:23

Protalix BioTherapeutics (AMEX:PLX) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate ...

Core News & Articles
Earnings Scheduled For May 9, 2025
05/09/2025 08:32:15

uncovering-potential-protalix-biotherapeuticss-earnings-preview
Uncovering Potential: Protalix BioTherapeu...
05/08/2025 18:02:54

protalix-biotherapeutics-says-with-debt-fully-repaid-its-well-positioned-to-execute-strategy-through-2025-and-beyond
Protalix BioTherapeutics Says With Debt Fu...
03/17/2025 15:56:28

Protalix saw record revenue growth in 2024, driven by increased sales to Chiesi, Pfizer, and Brazil. The company aims to start ...

protalix-biotherapeutics-fy-2024-gaap-eps-004-beats-001-estimate-sales-5340m-miss-5394m-estimate
Protalix BioTherapeutics FY 2024 GAAP EPS ...
03/17/2025 11:00:39

Protalix BioTherapeutics (AMEX:PLX) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of...

earnings-scheduled-for-march-17-2025
Earnings Scheduled For March 17, 2025
03/17/2025 08:32:11

hc-wainwright--co-maintains-buy-on-protalix-biotherapeutics-raises-price-target-to-15
HC Wainwright & Co. Maintains Buy on Prota...
02/03/2025 11:51:18

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Protalix BioTherapeutics (AMEX:PLX) with a Buy and raises the p...

chiesi-global-rare-diseases-a-business-unit-of-the-chiesi-and-protalix-biotherapeutics-announced-that-the-european-medicines-agency-has-validated-the-variation-submission-for-pegunigalsidase-alfa-to-label-a-less-frequent-dosing-regimen
Chiesi Global Rare Diseases, A Business Un...
12/09/2024 11:47:24

Chiesi Global Rare Diseases, a business unit of the Chiesi and Protalix BioTherapeutics announced that the European Medicines A...

protalix-biotherapeutics-q3-2024-gaap-eps-003-misses-006-estimate-sales-1796m-beat-1626m-estimate
Protalix BioTherapeutics Q3 2024 GAAP EPS ...
11/14/2024 11:54:44

Protalix BioTherapeutics (AMEX:PLX) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate ...

earnings-scheduled-for-november-14-2024
Earnings Scheduled For November 14, 2024
11/14/2024 08:32:28

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION